Sandoz Group AG (SDZXF)

OTCMKTS · Delayed Price · Currency is USD
51.98
-0.02 (-0.04%)
At close: Jun 17, 2025
42.70%
Market Cap 23.19B
Revenue (ttm) 10.38B
Net Income (ttm) n/a
Shares Out n/a
EPS (ttm) n/a
PE Ratio n/a
Forward PE 16.02
Dividend 0.73 (1.41%)
Ex-Dividend Date Apr 17, 2025
Volume 4,411
Average Volume 739
Open 51.98
Previous Close 52.00
Day's Range 51.98 - 51.98
52-Week Range 35.58 - 52.00
Beta n/a
RSI 70.78
Earnings Date Aug 7, 2025

About Sandoz Group AG

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland. [Read more]

Sector Healthcare
Founded 1886
Employees 22,049
Stock Exchange OTCMKTS
Ticker Symbol SDZXF
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.